BioWorld: Other news to note

“Shangpharma Innovation Inc., of South San Francisco, inked a multiyear strategic collaboration with the Icahn School of Medicine at Mount Sinai designed to accelerate the development of early stage therapeutics, including validation of drug targets and establishment of drug discovery programs. Additional terms were not disclosed.

Sinai, New York, N.Y.

Business: Pharmaceuticals”

*no link available

Media Inquiries

Heidi Chokeir, Ph.D.
Canale Communications
[email protected]